A recent New York Times piece looks at the effect of celiac disease on the brain. The story details what appeared to be sudden neurological or psychiatric symptoms, including seizures and hallucinations, that were eventually linked to patients’ celiac disease. The patients improved on a gluten-free diet after medications aimed at treating the neurologic symptoms failed.
Although celiac disease is notoriously difficult to diagnose, because of different symptoms among different patients, one study estimated that less than one half of all celiac candidates are being properly screened for the disease.
A gastrointestinal condition that presents with similar symptoms is known as sprue-like enteropathy. Symptoms include chronic diarrhea, vomiting, and excessive weight loss and the condition is commonly misdiagnosed as celiac disease. Sprue-like enteropathy has been associated with the prescription blood pressure medication, Omesartan, and can result in permanent injuries. Olmesartan is used to treat high blood pressure and is marketed under the brand names Benicar, Benicar HCT, Azor, and Tribenzor.
Celiac disease is an autoimmune disorder of the gut that is triggered by gluten. The disease is diagnosed through antibody tests and intestinal biopsy. Beyond the inflammation absorption issues commonly associated with celiac disease, other symptoms include rashes, nerve pain, and lost muscle control. Now, there is a question of whether some neurological symptoms may also be related to the disease.
The attorneys at Lopez McHugh are actively litigating Olmesartan/Benicar lawsuits. A Lopez McHugh Benicar lawyer can promptly evaluate your potential Benicar lawsuit, free of charge. Contact us today at (877) 737-8525 to schedule a free consultation or simply complete our online contact form. Call now, because every lawsuit is subject to strict deadlines for filing.
